Q1 Financial and Business Update

May 15, 2024 - 8:00 am ET

1-800-806-5484 (US or Canada)
+416-340-2217 (International and additional options available HERE).

Investor Relations Contact Information

T: 215-825-9306

IR@adaptimmune.com

For other contact information, please visit the Contact page.